A new paradigm in the treatment of bladder diseases
TARIS Biomedical is a leader in the local sustained
delivery of therapeutics to the genitourinary system.
TARIS is employing its core technology platform to develop a pipeline of novel
therapeutics focused on high unmet need disease areas in which current
therapies or systemic treatments have failed, with an initial focus on
diseases of the urinary bladder.
Read More
News and Events
November 30, 2011
TARIS Initiates Phase 2 Clinical Study with LiRIS in Interstitial Cytitis Patients
READ MORE
July 25, 2011
TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
READ MORE